» Articles » PMID: 22922558

A Single-day Paradigm of Self-regulated Human Cocaine Administration

Overview
Publisher Elsevier
Date 2012 Aug 28
PMID 22922558
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Prior work by our group has shown the feasibility, safety, and validity of a multi-day, multi-dose paradigm of self-regulated cocaine administration in humans. The current work sought to consolidate these methods in a single-day design focused on reducing logistical complexity, decreasing research burden to human subjects, and increasing suitability for medication development designs.

Methods: Eleven experienced cocaine users participated in a 6-hour, single-day design, consisting of one safety/eligibility and three experimental cocaine periods (during which subjects were allowed to self-administer 8, 16, and 32 mg/70 kg cocaine doses under a fixed-ratio 1:5 minute timeout schedule). Changes in cocaine-induced cardiovascular response, self-administration behavior, and subjective effects were assessed.

Results: Procedures were well tolerated by participants, and no significant adverse events were noted. Significant (p < 0.05), changes in measures of cocaine self-administration (e.g., responses, infusions, interinfusion intervals, consumption, and plasma levels), cardiovascular response (HR), and subjective effects (“high”) were observed. In contrast, cocaine-induced increases in other vital signs (e.g., SBP, DBP) and subjective effect measures (e.g., paranoia) did not differ between doses.

Conclusions: These data support the safety, tolerability and validity of our single-day design. Depending on the application, such methods may afford advantages for assessing the self-regulation of cocaine administration behavior in humans (e.g., including medication development designs).

Citing Articles

Cocaine self-administration behavior is associated with subcortical and cortical morphometry measures in individuals with cocaine use disorder.

Kohler R, Zhornitsky S, Potenza M, Yip S, Worhunsky P, Angarita G Am J Drug Alcohol Abuse. 2024; 50(3):345-356.

PMID: 38551365 PMC: 11305926. DOI: 10.1080/00952990.2024.2318585.


Discriminating cocaine use from other sympathomimetics using wearable electrocardiographic (ECG) sensors.

Angarita G, Pittman B, Nararajan A, Mayerson T, Parate A, Marlin B Drug Alcohol Depend. 2023; 250:110898.

PMID: 37523916 PMC: 10905422. DOI: 10.1016/j.drugalcdep.2023.110898.


Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies.

Regnier S, Lile J, Rush C, Stoops W J Exp Anal Behav. 2022; 117(3):420-441.

PMID: 35229294 PMC: 9090960. DOI: 10.1002/jeab.744.


Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.

Angarita G, Matuskey D, Pittman B, Costeines J, Potenza M, Jastreboff A Drug Alcohol Depend. 2021; 221:108614.

PMID: 33621809 PMC: 8026565. DOI: 10.1016/j.drugalcdep.2021.108614.


Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Cunningham K, Anastasio N Neuropharmacology. 2013; 76 Pt B:460-78.

PMID: 23850573 PMC: 4090081. DOI: 10.1016/j.neuropharm.2013.06.030.


References
1.
Schlaepfer T, Pearlson G, Wong D, Marenco S, Dannals R . PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry. 1997; 154(9):1209-13. DOI: 10.1176/ajp.154.9.1209. View

2.
FISCHMAN M, Schuster C, Rajfer S . A comparison of the subjective and cardiovascular effects of cocaine and procaine in humans. Pharmacol Biochem Behav. 1983; 18(5):711-6. DOI: 10.1016/0091-3057(83)90011-4. View

3.
Foltin R, FISCHMAN M . Methods for the assessment of abuse liability of psychomotor stimulants and anorectic agents in humans. Br J Addict. 1991; 86(12):1633-40. DOI: 10.1111/j.1360-0443.1991.tb01758.x. View

4.
Morgan P, Malison R . Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence. Am J Drug Alcohol Abuse. 2008; 34(6):692-702. DOI: 10.1080/00952990802308221. View

5.
Newton , Kalechstein , Beckson , Bartzokis , Bridge , Ling . Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Res. 1999; 87(2-3):101-6. DOI: 10.1016/s0165-1781(99)00058-x. View